Literature DB >> 20011280

Medical treatment of ulcerative colitis.

Uma Mahadevan1.   

Abstract

Ulcerative colitis is a chronic inflammatory disease of the colon with an increasing incidence worldwide. The medical management of this disease continues to expand as drugs to induce and maintain remission are sought to avoid the need for colectomy. This article will review the standard of care for the treatment of mild, moderate, and severe ulcerative colitis. The efficacy, optimal usage, and adverse events profile of agents such as 5-aminosalicylates, corticosteroids, azathioprine, and cyclosporine will be discussed and an algorithm for their use will be developed. Alternative and experimental therapies such as monoclonal antibodies, probiotics, and heparin will also be addressed.

Entities:  

Keywords:  Ulcerative colitis; cyclosporine; medical therapy

Year:  2004        PMID: 20011280      PMCID: PMC2780076          DOI: 10.1055/s-2004-823066

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  149 in total

1.  Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

Authors:  J H BARON; A M CONNELL; T G KANAGHINIS; J E LENNARD-JONES; A F JONES
Journal:  Br Med J       Date:  1962-08-18

2.  Changes in extent of ulcerative colitis: a study on the course and prognostic factors.

Authors:  E Langholz; P Munkholm; M Davidsen; O H Nielsen; V Binder
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

3.  Non-smoking: a feature of ulcerative colitis.

Authors:  A D Harries; A Baird; J Rhodes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

4.  Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.

Authors:  Gerald A Dayharsh; Edward V Loftus; William J Sandborn; William J Tremaine; Alan R Zinsmeister; Thomas E Witzig; William R Macon; Lawrence J Burgart
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Authors:  A B Hawthorne; R F Logan; C J Hawkey; P N Foster; A T Axon; E T Swarbrick; B B Scott; J E Lennard-Jones
Journal:  BMJ       Date:  1992-07-04

6.  Treatment of ulcerative colitis with hydrocortisone enemas. Comparison of absorption and clinical response with hydrocortisone alcohol and hydrocortisone acetate.

Authors:  R G Farmer; O P Schumacher
Journal:  Am J Gastroenterol       Date:  1970-09       Impact factor: 10.864

7.  Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.

Authors:  Gert Van Assche; Geert D'Haens; Maja Noman; Séverine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  [Chronic interstitial nephritis and mesalazine: 3 new cases?].

Authors:  M Brouillard; J D Gheerbrant; Y Gheysens; D Fleury; M Devred; M Hazzan; J F Colombel
Journal:  Gastroenterol Clin Biol       Date:  1998 Aug-Sep

9.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors:  W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

10.  Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

Authors:  R C Evans; V S Wong; A I Morris; J M Rhodes
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171

View more
  13 in total

1.  Arjunarishta alleviates experimental colitis via suppressing proinflammatory cytokine expression, modulating gut microbiota and enhancing antioxidant effect.

Authors:  Damita Cota; Sanjay Mishra; Sushant Shengule
Journal:  Mol Biol Rep       Date:  2020-09-03       Impact factor: 2.316

2.  Pros and cons of medical management of ulcerative colitis.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Clin Colon Rectal Surg       Date:  2010-12

3.  A Thermo-Sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies.

Authors:  Sidhartha R Sinha; Linh P Nguyen; Mohammed Inayathullah; Andrey Malkovskiy; Frezghi Habte; Jayakumar Rajadas; Aida Habtezion
Journal:  Gastroenterology       Date:  2015-04-08       Impact factor: 22.682

4.  Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease.

Authors:  Shrey Kanvinde; Yashpal Singh Chhonker; Rizwan Ahmad; Fei Yu; Richard Sleightholm; Weimin Tang; Lee Jaramillo; Yi Chen; Yuri Sheinin; Jing Li; Daryl J Murry; Amar B Singh; David Oupický
Journal:  Acta Biomater       Date:  2018-10-17       Impact factor: 8.947

5.  Specific immunotherapy plus Clostridium butyricum alleviates ulcerative colitis in patients with food allergy.

Authors:  Fan Yang; Dong Lu; Zhenlv Lin
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

6.  Specific immunotherapy ameliorates ulcerative colitis.

Authors:  Min Cai; Lu Zeng; Lin-Jing Li; Li-Hua Mo; Rui-Di Xie; Bai-Sui Feng; Peng-Yuan Zheng; Zhi-Gang Liu; Zhan-Ju Liu; Ping-Chang Yang
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-05       Impact factor: 3.406

7.  A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.

Authors:  Gionata Fiorino; Giacomo Carlo Sturniolo; Fabrizio Bossa; Andrea Cassinotti; Antonio di Sabatino; Paolo Giuffrida; Silvio Danese
Journal:  Cells       Date:  2019-05-30       Impact factor: 6.600

Review 8.  Optimal management of steroid-dependent ulcerative colitis.

Authors:  Hafiz M Waqas Khan; Faisal Mehmood; Nabeel Khan
Journal:  Clin Exp Gastroenterol       Date:  2015-11-12

9.  Early Outcome of Patient with Ulcerative Colitis who Received High Dose of Steroid and Underwent Two Staged Total Proctocolectomy.

Authors:  Hajar Khazraei; Alimohammad Bananzadeh; Seyed Vahid Hosseini
Journal:  Adv Biomed Res       Date:  2018-01-30

10.  Solitary rectal ulcer syndrome: addition of rectal therapies to biofeedback is more effective than biofeedback alone.

Authors:  Saeed Abdi; Narjes Tavakolikia; Mehdi Yamini; Mohammad Bagheri; Amir Sadeghi; Mohamad Amin Pourhoseingholi; Shabnam Shahrokh; Morteza Aghajanpoor Pasha
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.